Skip to main content

ILLUMINA INC

For the period ended Dec 31, 2023. Filed Feb 16, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 16, 2024

ILMN$214.91-2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

7. Supplemental Balance Sheet and Statement of Operations Details

Accounts Receivable

In millionsDecember 31,2023January 1,2023
Trade accounts receivable, gross$741$675
Allowance for credit losses(7)(4)
Total accounts receivable, net$734$671

Inventory

In millionsDecember 31,2023January 1,2023
Raw materials$276$247
Work in process402386
Finished goods3028
Inventory, gross708661
Inventory reserve(121)(93)
Total inventory, net$587$568

Property and Equipment

In millionsDecember 31,2023January 1,2023
Leasehold improvements$803$759
Machinery and equipment684644
Computer hardware and software463424
Furniture and fixtures5550
Buildings4444
Construction in progress96132
Total property and equipment, gross2,1452,053
Accumulated depreciation(1,138)(962)
Total property and equipment, net$1,007$1,091

Property and equipment, net included non-cash expenditures of $12 million, $16 million and $17 million in 2023, 2022, and 2021, respectively, which were excluded from the consolidated statements of cash flows.

Accrued Liabilities

In millionsDecember 31,2023January 1,2023
Legal contingencies(1)$484$473
Contract liabilities, current portion252245
Accrued compensation expenses(2)223188
Accrued taxes payable7997
Operating lease liabilities, current portion8676
Liability-classified equity incentive awards5536
Other, including warranties(3)146117
Total accrued liabilities$1,325$1,232

(1)See note “8. Legal Proceedings” for additional details.

(2)Included employee separation costs related to restructuring activities.

(3)See table below for changes in the reserve for product warranties.

Changes in the reserve for product warranties were as follows:

In millions
Balance as of January 3, 2021$13
Additions charged to cost of product revenue33
Repairs and replacements(24)
Balance as of January 2, 202222
Additions charged to cost of product revenue23
Repairs and replacements(27)
Balance as of January 1, 202318
Additions charged to cost of product revenue42
Repairs and replacements(39)
Balance as of December 31, 2023$21

Restructuring

In Q2 2023, we implemented a cost reduction initiative that included workforce reductions, the consolidation of certain facilities and other actions to reduce expenses, all as part of a plan to realign operating expenses while maintaining focus on our innovation roadmap and sustainable long-term growth. In 2023, we recorded pre-tax restructuring charges primarily consisting of asset impairment charges related to our facilities and employee separation costs.

A summary of the pre-tax restructuring charges recorded in 2023 are as follows:

In millions
Employee separation costs$48
Asset impairment charges (1)100
Other costs4
Total restructuring charges (2)$152

(1)Primarily related to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses in California.

(2)For 2023, $122 million was recorded in SG&A expense, $24 million in R&D expense, with the remainder recorded in cost of revenue. These restructuring activities primarily relate to our Core Illumina segment.

During 2023, we fully exited our i3 campus in San Diego, California, which resulted in a right-of-use asset impairment of $38 million, and we exited a portion of our campus in Foster City, California, which resulted in a right-of-use asset impairment of $21 million. These impairments were recognized in selling, general and administrative expense. The impairments were determined by comparing the fair value of the impacted right-of-use asset to the carrying value of the asset as of the impairment measurement date. The fair value of the right-of-use asset was estimated using the discounted future cash flows method, which includes estimates and assumptions for future sublease rental rates that reflect current sublease market conditions, as well as a discount rate. The estimates and assumptions used in our assessment represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. We also recorded $16 million and $22 million of leasehold improvement impairments related to the exits of our i3 and Foster City campuses, respectively, in 2023, recognized in selling, general and administrative expense. We continue to evaluate our options with respect to the rest of our campus in Foster City, California. As of December 31, 2023, we had remaining assets, consisting primarily of right-of-use assets and leasehold improvements, related to our Foster City campus of approximately $136 million.

A summary of the restructuring liability is as follows:

In millionsEmployee Separation Costs (1)Other CostsTotal
Expense recorded in 2023$48$4$52
Cash paid during 2023(31)(3)(34)
Amount recorded in accrued liabilities as of YTD 2023$17$1$18
Estimated total restructuring costs to still be incurred$8$—$8

(1)It is expected that substantially all of the employee separation related restructuring charges will be incurred and paid by the end of Q1 2024.

Other (Expense) Income, Net

In millions202320222021
Gain on previously held investment in GRAIL$—$—$899
Gain on exchange of GRAIL contingent value rights——86
Gain (loss) on Helix contingent value right10(7)30
Gain on derivative assets related to terminated acquisition——26
(Losses) gains on strategic investments, net(40)(122)18
Other1(13)9
Other (expense) income, net$(29)$(142)$1,068
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.